Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of ...

If a language can be used to build web scrapers, it definitely needs to provide a graceful data visualization library. --- by dongdong. In the Golang ecosystem, there are not many choices for data ...

Human immunodeficiency virus (HIV) is a virus that attacks the body's immune system. HIV is a manageable chronic condition. With treatment, people living with HIV can have long and healthy lives.

Investors' focus will likely be on GILD's HIV franchise performance and oncology sales when the company reports ...

The European Commission (EC) has authorised the use of ViiV Healthcare’s Vocabria (cabotegravir long-acting injections) plus ...

The new administration's freeze on foreign aid (affecting America's sweeping anti-HIV initiative PEPFAR) has raised concerns about the dispersal of the pills taken daily by those who are HIV positive.

“Easing the medication burden and economic losses posed by the current HIV regimen, especially in developing countries, is critical.” During their new study, Wender and colleagues wanted to ...

Results: Median CD4+ cell counts and HIV-RNA plasma viremia were comparable in the four ... after 12 months of therapy confirms the potency of modern day antiretroviral regimens. The observation that ...

After abruptly pausing PEPFAR on Tuesday — the U.S.-led HIV/AIDS program created in 2003 and credited ... That forces someone to move onto a second or third line regimen of drugs that are pricier and ...

LONDON - The European Commission has authorized the use of Vocabria and Rekambys, a long-acting injectable regimen, for adolescents living with HIV-1, ViiV Healthcare, majority-owned by GSK (NYSE: GSK ...

LONDON - The European Commission has authorized the use of Vocabria and Rekambys, a long-acting injectable regimen, for adolescents living with HIV-1, ViiV Healthcare, majority-owned by GSK (NYSE ...

(Gilead), marks a significant step in the development of a potential component for a curative regimen for HIV. The trial has enrolled 30 participants across five sites in the United States ...